Search Result "HDL-cholesterol levels"
New Approaches to Raising the HDL Cholesterol Level
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2 Issue: 3 Year: 2002 Page: 271-276
Author(s): Hisashi Shinkai
Pharmacotherapy and HDL Cholesterol
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 4 Year: 2005 Page: 309-314
Author(s): A. Dart
Atheroprotective Effects of HDL: Beyond Reverse Cholesterol Transport
Journal: Current Drug Targets
Volume: 9 Issue: 3 Year: 2008 Page: 196-203
Author(s): Edward A. Fisher, Jonathan E. Feig, Raanan Shamir
HDL - Cholesterol: The New Target for Treatment
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4 Issue: 2 Year: 2010 Page: 153-160
Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal, Ashraf Ganie
Therapeutic Targeting of HDL and Reverse Cholesterol Transport
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 4 Year: 2005 Page: 299-307
Author(s): D. Sviridov
Can We Change the Functionality of HDL Cholesterol with Nonpharmacological and Pharmacological Agents?
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2927-2946
Author(s): S. Dragan,C. Serban,M. Banach
Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3841-3857
Author(s): Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano
Novel Insights of ANGPTL-3 on Modulating Cholesterol EffluxCapacity Induced by HDL Particle
Journal: Current Molecular Medicine
Volume: 24 Issue: 6 Year: 2024 Page: 771-779
Author(s):
ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis
Journal: Current Drug Targets
Volume: 12 Issue: 5 Year: 2011 Page: 647-660
Author(s): Dan Ye, Bart Lammers, Ying Zhao, Illiana Meurs, Theo J.C. Van Berkel, Miranda Van Eck
Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL Cholesterol
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 16 Issue: 4 Year: 2016 Page: 270-275
Author(s): Giovanni De Pergola,Vincenzo Triggiani,Nicola Bartolomeo,Adele Nardecchia,Vito Angelo Giagulli,Irene Bruno,Domenico Caccavo,Franco Silvestris